Transplantation And Cellular Therapy

Transplantation And Cellular Therapy

移植和细胞治疗

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Transplantation And Cellular Therapy》是由Elsevier出版社创办的英文国际期刊(ISSN: 2666-6375,E-ISSN: 2666-6367),该期刊长期致力于血液学领域的创新研究,主要研究方向为Medicine-Hematology。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA开放获取模式(OA占比%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比94.58%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在295篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Transplantation And Cellular Therapy审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约295篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • None 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 295 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植
3区 3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 TRANSPLANTATION 移植 IMMUNOLOGY 免疫学
2区 2区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 25 / 97

74.7%

学科:IMMUNOLOGY SCIE Q2 86 / 181

52.8%

学科:TRANSPLANTATION SCIE Q1 7 / 31

79%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 24 / 97

75.77%

学科:IMMUNOLOGY SCIE Q2 48 / 181

73.76%

学科:TRANSPLANTATION SCIE Q2 8 / 31

75.81%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7 SJR:1.602 SNIP:1.113
学科类别 分区 排名 百分位
大类:Medicine 小类:Transplantation Q1 11 / 54

80%

大类:Medicine 小类:Hematology Q1 30 / 137

78%

大类:Medicine 小类:Immunology and Allergy Q2 82 / 233

65%

大类:Medicine 小类:Molecular Medicine Q2 66 / 178

63%

大类:Medicine 小类:Cell Biology Q2 128 / 285

55%

期刊发文

  • Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China

    Author: Gong, Susu; Chen, Cong; Chen, Keke; Yang, Rui; Wang, Leyuan; Yang, Kaitai; Hu, Jian; Nie, Lin; Su, Tao; Xu, Yajing; He, Xianglin; Yang, Liangchun; Xiao, Hong; Fu, Bin

    Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 480-480000000. DOI: 10.1016/j.jtct.2022.10.006

  • Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients

    Author: Deng, Rui-Xin; Zhu, Xiao-Lu; Zhang, Ao-Bei; He, Yun; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting -Ting; Chen, Yu -Hong; Chang, Ying-Jun; Xu, Lan -Ping; Huang, Xiao-Jun; Zhang, Xiao-Hui

    Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 570-570000000000. DOI: 10.1016/j.jtct.2022.10.007

  • Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement

    Author: Miao, Fujia; Ren, Guisheng; Guo, Jinzhou; Zhao, Liang; Xu, Weiwei; Huang, Xianghua

    Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 2, pp. 1100-11000000000. DOI: 10.1016/j.jtct.2022.10.021

  • Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy

    Author: Li, Zhihui; An, Na; Yang, Keyan; Meng, Fanqiao; Xu, Teng; Peng, Xiaojuan; Wen, Xiaopei; Li, Jing; Song, Yanzhi; Yang, Rui; Wu, Tong

    Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 3, pp. 167-173. DOI: 10.1016/j.jtct.2022.11.013

  • A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

    Author: Zhang, Ao-Bei; Wang, Chen-Cong; Zhao, Peng; Tong, Ke-Ting; He, Yun; Zhu, Xiao-Lu; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Zhao, Xiang-Yu; Zhang, Yuan-Yuan; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting-Ting; Sun, Yu-Qian; Chen, Yu-Hong; Chang, Ying-Jun; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun; Zhang, Xiao-Hui

    Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 4, pp. -. DOI: 10.1016/j.jtct.2022.12.008